News

Taiwan News21d
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform | Taiwan News | Jun. 4, 2025 19:00 - 台湾新闻
REHOVOT, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek ...
Mena FN21d
Purple Biotech Announces Poster Presentation At EACR 2025 On Its Novel CAPTN-3 Tri-Specific Antibody Platform - MENAFN.COM
REHOVOT, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (Purple Biotech or the Company) (NASDAQ/TASE: PPBT), a clinical-stage comp Tuesday, 02 January 2024 12:17 GMT عربي ...
Morningstar21d
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform - Morningstar
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform Provided by GlobeNewswire Jun 4, 2025, 11:00:00 AM ...
Aktien Check21d
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform - aktiencheck.de
Purple Biotech Announces Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Platform | aktiencheck.de. LSR. LSR.